Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Co-culturing method of human primary hepatocytes and liver nonparenchymal cells

A technology of liver non-parenchymal cells and primary liver cells, applied in artificial cell constructs, animal cells, vertebrate cells, etc., can solve the problem of losing differentiation characteristics, not supporting HBV infection, and not reflecting the antiviral effect of drugs and cytotoxicity Function and other issues, to achieve the effect of overcoming the loss

Active Publication Date: 2015-02-18
康珞生物科技(常州)有限公司
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the serious dedifferentiation of these cell lines, compared with the liver cells in vivo, the differentiation state is far different, so the real antiviral effect and cytotoxicity of the drug cannot be reflected in the screening and evaluation of anti-HBV drugs
To make matters worse, these cell lines do not support HBV infection and cannot be used for research on anti-HBV infectious drugs such as small peptides, antibodies, etc.
Human primary hepatocytes are the most ideal cell infection model for HBV research. A large number of studies have shown that primary hepatocytes can be infected by HBV, but they quickly lose their differentiation characteristics when cultured in vitro, and the susceptibility to HBV is usually within 1 week. It is completely lost, which seriously restricts the establishment of cell models for the study of HBV infection mechanism, drug screening and evaluation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Co-culturing method of human primary hepatocytes and liver nonparenchymal cells
  • Co-culturing method of human primary hepatocytes and liver nonparenchymal cells
  • Co-culturing method of human primary hepatocytes and liver nonparenchymal cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] In order to better explain the present invention, the main content of the present invention is further clarified below in conjunction with specific examples, but the content of the present invention is not limited to the following examples.

[0034] 1. Two-step collagenase perfusion method to separate primary human hepatocytes and liver non-parenchymal cells:

[0035] The first step of the two-step collagenase perfusion method: the fresh liver tissue material is perfused with perfusion solution I for about 30 minutes through the exposed blood vessels until the blood in the liver tissue is washed away. The specific formula of perfusion solution I is: 8.00g / l sodium chloride, 0.40g / l potassium chloride, 3.57g / l hydroxyethylpiperazineethanesulfonic acid, 0.06g / l disodium hydrogen phosphate dihydrate, 0.06g / l potassium dihydrogen phosphate, 1 g / l glucose, 1 mM sodium pyruvate, 2 mM ethylene glycol bis(2-aminoethyl ether) tetraacetic acid, adjust the pH to 7.4, filter and s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a co-culturing method of human primary hepatocytes and liver nonparenchymal cells. The co-culturing method comprises following steps: fresh hepatic tissue is washed thoroughly with exposed blood vessel perfusate I and perfusate II until elasticity of the hepatic tissue is lost, and complete digestion is realized; the hepatic tissue is delivered into a culture dish filled with a cell washing liquor, and is screened so as to obtain a single-cell suspension; a culture plate or a culture dish coated with collagen is inoculated with the single-cell suspension with a low inoculum density so as to obtain monolayer co-cultured cells with a fusion degree of 100% in the presence of growth factors; and a maintaining culture medium containing 2% DMSO is added into the culture plate or the culture dish for culturing, and then a liver island structure is formed by accumulation of hepatic cells, wherein the liver island structure is surrounded and invaded by liver nonparenchymal cells. Routine hepatocyte separation technology is employed in the co-culturing method, in vitro long-term culturing of hepatocytes as long as 120 days are realized, and HBV susceptibility is maintained for as long as 72 days. In addition, the co-culturing method can be used for screening and evaluating anti-HBV medicines, and possesses significant importance on researches of antiviral medicines.

Description

technical field [0001] The invention relates to a cell culture method, in particular to a simple co-cultivation method of hepatocytes and liver non-parenchymal cells that can maintain the characteristics of human primary hepatocytes and the susceptibility to HBV for a long time. Background technique [0002] Liver cells can be divided into hepatic parenchymal cells and hepatic non-parenchymal cells in terms of function. Cells, sinusoidal endothelial cells, hepatic epithelial cells, Kupffer cells, etc., mainly perform the functions of auxiliary liver cells, liver immunity and liver structural support. So far, the traditional co-culture method is to mix and culture pure primary hepatocytes and pure hepatic non-parenchymal cells in a certain proportion. Therefore, the morphological characteristics and physiological functions of primary hepatocytes can be maximally maintained. However, this traditional co-culture system has serious disadvantages, such as limited cell lifespan,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/071
Inventor 胡康洪周明曹晓蓓
Owner 康珞生物科技(常州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products